POSTDOCTORAL RESEARCHER - THE MYELODYSPLASTIC SYNDROMES GROUP

Reference

PR_FS_58

Places available

1

Deadline for application

13/08/2021

Requirements

What we need 

- Great interest and vocation for biomedical research and a great capacity for learning.
- Great organizational skills and a very flexible attitude.
 - Great communication and teamwork skills.
- Proactive attitude, with initiative and ability to seek solutions.
- Knowledge of the biological basis of hematological neoplasms.
- Knowledge of the techniques of arrays, NGS, single cell, conservation of biological samples and knowledge of bioinformatics will be an asset.
- Great ability to adapt to new situations, methodologies and colleagues.
- High ability to understand, write and speak English.
- PhD completed or in development.

 

What we offer:

- Work in a dynamic and young team.
- Molecular training in translational research in the field of hematology.
- 3-year contracts.
- Incorporation 1st October 2021.

Additional Information

The Josep Carreras Leukaemia Research Institute (IJC) is a non-profit research institute based in Barcelona and dedicated to advancing our understanding about leukaemia and related disorders, in partnership with the University of Barcelona and University Autònoma of Barcelona. The IJC has laboratories in three clinical campuses: i) Clinic Hospital, ii) Sant Pau Hospital and iii) Germans Trias i Pujol Hospital. IJC serves as a collaborative hub for basic investigators and physicians to work together on fundamental biological and clinical aspects of leukaemia. The IJC offers an excellent work environment built around a multi-disciplinary fusion of ideas and state-of-the-art facilities.

 

Research Description

Postdoctoral position is offered to coordinate the projects of the Myelodysplastic Syndromes Group led by Dr. Francesc Solé, at the Institut de Recerca contra la Leucèmia Josep Carreras/Campus ICO-GTIP, Badalona. The work will focus on genomic and functional aspects of MDS and other myeloid haematological malignancies, using techniques such as SNP arrays, massive targeted or exome sequencing and single cell genomic and transcriptomic studies. Please also visit our group webpage: https://www.carrerasresearch.org/es/Myelodysplastic_Syndromes

This contract is funded by the project DJCLS 01 R/2021 - Dissecting the mechanisms of malignant transformation in del(5q) myelodysplastic syndrome to selectively target the disease-initiating hematopoietic stem cells.

 

Who we are?

Our mission is to carry out research into the basic, epidemiological, preventive, clinical and translational aspects of leukaemia and other hematologic malignancies.

The vision of the Josep Carreras Leukaemia Research Institute is that research will identify new therapeutic targets and enable us to develop more precise and less aggressive treatments.  We aspire to understand the origin and development of leukaemia and other malignant haematological pathologies in order to be able to prevent them.  We will work for a future in which all leukaemias will be curable.

For further information, please, visit our webpage: http://www.carrerasresearch.org/enand the Josep Carreras non-profit organization:https://www.fcarreras.org/en

The European Commission awarded the IJC the HR Excellence seal in July 2019. The IJC continues to work to maintain its policies in line with the Charter and Code principles.

The HRS4R has the main objective of ensuring that research centers of excellence implement and respect the requirements of the European

Charter for Researchers and the Code of Conduct for hiring researchers (from here on referred to as the Charter and Code) within their human resources policies.

This EC initiative aims to promote training, professional development, and mobility for all European scientists.  The IJC supports these values and principles, which will not only serve to strengthen its internal policies but will actively stimulate excellent research andfirmly situate the organization as an institution with a stimulating working environment that favors the development of its scientists.

IJC is an equal opportunity employer. We evaluate qualified applicants without regard to race, color, religion, sex, national origin, disability, and other legally protected characteristics.

Place of presentation of the candidacies

How to apply

To apply for this opportunity, please send your resume and a cover letter (incl. the contact details of two referees) to jobs@carrerasresearch.org indicating in the subject of the message: REF.: PR_FS_58.

 

Deadline for Applications

Please submit your application by August 13th, 2021.

Enlaces relacionados